top of page
AI pixabay huge.jpg

Click Expands to Substance Use Disorder With Indivior Digital Therapeutics Pact

Digital therapeutics developer Click Therapeutics is partnering with Indivior to develop a mobile app for substance use disorder. Indivior is now Click’s third development partner, following deals with Boehringer Ingelheim and Otsuka Pharmaceutical.





Commentaires


bottom of page